RETAILERS PREPARING FOR HOT TAGAMET HB

Supermarket retailers are quickly adjusting their stomach remedy schematics as Tagamet HB, the second product in the fast emerging H2 antagonist segment, goes from prescription to over-the-counter early this fall.With Pepcid AC (Johnson & Johnson/Merck Pharmaceuticals, Fort Washington, Pa.) on the shelves since June, Zantac (Glaxo Wellcome, London) slated for conversion within the next year and Axid

Supermarket retailers are quickly adjusting their stomach remedy schematics as Tagamet HB, the second product in the fast emerging H2 antagonist segment, goes from prescription to over-the-counter early this fall.

With Pepcid AC (Johnson & Johnson/Merck Pharmaceuticals, Fort Washington, Pa.) on the shelves since June, Zantac (Glaxo Wellcome, London) slated for conversion within the next year and Axid (Whitehall-Robins, Madison, N.J.) under review by the Food and Drug Administratio

Register to view the full article

Already a member? .

TAGS: Supervalu